Addressing Unmet Needs in Vaccination for Older Adults in the Asia Pacific: Insights from the COVID-19 Pandemic

Abstract The impact of vaccinating the older population against vaccine-preventable diseases in terms of health, social and economic benefits has been increasingly recognised. However, there is a gap in the utilisation of vaccines worldwide. The population is ageing at an unprecedented pace in the Asia-Pacific (APAC) region, with the number of persons older than 65 years set to double by 2050 to around 1.3 billion. More than 18% of the population in Japan, Hong Kong, and China is over the age of 65 years. This highlights the importance of prioritising resources to address societal obligations toward the needs of the ageing generation. This review provides an overview of the challenges to adult vaccination in APAC, drivers to increase vaccination coverage, vaccination insights gained through the COVID-19 pandemic, and potential measures to increase the uptake of adult vaccines in the region.

[1]  M. Batista,et al.  Third-Generation Vaccines: Features of Nucleic Acid Vaccines and Strategies to Improve Their Efficiency , 2022, Genes.

[2]  M. Hosoda.  Vaccine Hesitancy in Japan: From a Perspective on Medical Uncertainty and Trans-Scientific Theory , 2022, F1000Research.

[3]  Y. L. Koh,et al.  A multidisciplinary effort to increase COVID-19 vaccination among the older adults , 2022, Frontiers in Public Health.

[4]  Z. Hou,et al.  Influenza vaccination hesitancy and its determinants among elderly in China: A national cross-sectional study. , 2022, Vaccine.

[5]  Dodik Pramono,et al.  Determinant Factors of COVID-19 Vaccine Hesitancy Among Adult and Elderly Population in Central Java, Indonesia , 2022, Patient preference and adherence.

[6]  Guangyu Hu,et al.  Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review , 2022, Vaccines.

[7]  Md Ariful Haque,et al.  Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic , 2021, Pathogens and global health.

[8]  Z. Hou,et al.  Public Interest in Distribution and Determinants of Influenza and Pneumonia Vaccination during the COVID-19 Pandemic: An Infodemiology and Cross-Sectional Study from China , 2021, Vaccines.

[9]  A. Amit,et al.  COVID-19 vaccine brand hesitancy and other challenges to vaccination in the Philippines , 2021, medRxiv.

[10]  A. Chakrabarti,et al.  Cohort profile: Indian Network of Population-Based Surveillance Platforms for Influenza and Other Respiratory Viruses among the Elderly (INSPIRE) , 2021, BMJ Open.

[11]  Saran Thanapluetiwong,et al.  Factors associated with COVID-19 Vaccine Hesitancy in Thai Seniors , 2021, Patient preference and adherence.

[12]  R. Tiwari,et al.  COVID-19 vaccine hesitancy – reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic , 2021, Human vaccines & immunotherapeutics.

[13]  John Federick C Yap,et al.  The role of religiosity in COVID-19 vaccine hesitancy , 2021, Journal of public health.

[14]  A. Vora,et al.  Vaccination in Older Adults: An Underutilized Opportunity to Promote Healthy Aging in India , 2021, Drugs & Aging.

[15]  M. Jiang,et al.  Preference of influenza vaccination among the elderly population in Shaanxi province, China , 2021, Human vaccines & immunotherapeutics.

[16]  Kathryn S. Campy,et al.  Factors associated with intention to uptake pneumococcal vaccines among Chinese elderly aged 60 years and older during the early stage of COVID-19 pandemic. , 2021, Psychology, health & medicine.

[17]  A. Majeed,et al.  Covid-19 vaccine hesitancy among ethnic minority groups , 2021, BMJ.

[18]  Malik Sallam.  COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates , 2021, Vaccines.

[19]  Junfen Lin,et al.  Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: A quasi-experimental study. , 2020, Vaccine.

[20]  A. Cripps,et al.  The impact of the changing pneumococcal national immunisation program among older Australians. , 2020, Vaccine.

[21]  D. Young,et al.  Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake. , 2020, Vaccine.

[22]  M. Jit,et al.  A global agenda for older adult immunization in the COVID-19 era: A roadmap for action , 2020, Vaccine.

[23]  J. Paguio,et al.  Silver lining of COVID-19: Heightened global interest in pneumococcal and influenza vaccines, an infodemiology study , 2020, Vaccine.

[24]  A. Cunningham,et al.  Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine , 2020, Human vaccines & immunotherapeutics.

[25]  B. Weinberger,et al.  Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives , 2020, Frontiers in Immunology.

[26]  Qiong Chen,et al.  Recommendations for influenza and Streptococcus pneumoniae vaccination in elderly people in China , 2020, Aging medicine (Milton (N.S.W)).

[27]  L. Wong,et al.  Vaccine hesitancy and the resurgence of vaccine preventable diseases: the way forward for Malaysia, a Southeast Asian country , 2020, Human vaccines & immunotherapeutics.

[28]  A. Di Pasquale,et al.  Towards adult vaccination in India: a narrative literature review , 2019, Human vaccines & immunotherapeutics.

[29]  I. Wu,et al.  Vaccination coverage and associated factors for receipt of the 23-valent pneumococcal polysaccharide vaccine in Taiwan , 2018, Medicine.

[30]  P. Koul,et al.  Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative. , 2017, Vaccine.

[31]  K. Goh,et al.  Factors associated with influenza vaccine uptake in older adults living in the community in Singapore , 2016, Epidemiology and Infection.

[32]  T. Adair,et al.  Equity in disease prevention: Vaccines for the older adults - a national workshop, Australia 2014. , 2016, Vaccine.

[33]  O. Park,et al.  Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure. , 2016, Vaccine.

[34]  M. H. Nguyen,et al.  Vaccination in Older Adults in Singapore: A Summary of Recent Literature , 2015 .

[35]  S. Olsen,et al.  Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010–2012 , 2014, Vaccine.

[36]  Yan Liu,et al.  Factors associated with pneumococcal vaccination among an urban elderly population in China , 2014, Human vaccines & immunotherapeutics.

[37]  P. Khanna,et al.  Vaccines for the elderly need to be introduced into the immunization program in India , 2014, Human vaccines & immunotherapeutics.

[38]  M. Woodward.  Immunisation of Older People , 2012 .

[39]  N. Kuriyama,et al.  Factors associated with influenza vaccination status of residents of a rural community in Japan , 2011, BMC Public Health.

[40]  G. Dinant,et al.  The Efficacy of Influenza Vaccination in Elderly Individuals: A Randomized Double-blind Placebo-Controlled Trial , 1994 .

[41]  J. S. Stevenson,et al.  Older Adults , 1980, Suicide Prevention.

[42]  松本 慶蔵,et al.  季節性インフルエンザ(Seasonal Influenza)の総括 , 2009 .

[43]  K. Edwards,et al.  Combination Vaccines , 1999, Humana Press.